COL1A1 and colorectal carcinoma: In colorectal cancer (CRC) specifically, miR-133 has been reported to target multiple oncogenic factors including LASP1 [22], TAGLN2 [13], FSCN1 [23], and COL1A1 [24], thereby suppressing proliferation, migration, and invasion.